2024 年 7 月 15 日
Firstly, why should you analyze validation metrics?
Analysis of your clinical validation analytics can inform your overall assessment and allow you to make process improvements that improve the quality and timeliness of submission data, while reducing overall costs and risks.
Below, we look at some examples of how Pinnacle 21 Enterprise Analytics (P21E) can help you make timely and informed decisions.
Case study 1: Projected Scores
挑战:We have different standards teams based on Therapeutic Area (TA), and we’d like to allocate more resources to help boost our Scores.
P21E Solution: The Projected Scores report allows us to filter by TA across data packages validated within the past year to see which TA’s Projected Scores fall below the median baseline. With this information, we’re able to determine where to concentrate our efforts and create more robust standards or provide further TA-specific training. Our effectiveness will be verified using the same report during the following year, where the updated analysis should show increased baseline Projected Scores across those chosen TAs.

Case study 2: Validation Frequency
挑战:We oversee several different studies, each with its own unique timelines for submission. We want to be sure validations are occurring as needed to meet specific milestones.
P21E Solution: By comparing our Master Study List to the Validation Frequency report, we’re able to ensure that as critical time points in each study approach, the number of validations increases. The ability to quantify this in real-time also gives us the power to recognize when validations are not occurring as expected and proactively work to resolve any discrepancies.

Case study 3: Top Unresolved Issues
挑战:We would like to develop our own Fix Tips and Explanations to guide our users and standardize more of the justifications for issues being sent to the agencies via the Data Reviewer’s Guides. However, it is too cumbersome to go through every single Rule ID or combine reports to find our portfolio’s most prevalent issues.
P21E Solution: Using the Top Unresolved Issues report, we’re able to view the top 50 issues by standard, date last validated, and data package status that are most frequently occurring across all studies. Sorting by Type further provides a starting point at which we can perform any root cause analyses to aid in the adjustment of our standards, forging of Fix Tips, or establishment of our Explanations.

Case study 4: Reject Issues
挑战:Studies cannot be successfully submitted with any issues that have an Impact or Severity of Reject; therefore, it is essential to monitor these types of issues across all trials to ensure they are being resolved as early in the validation life cycle as possible.
P21E Solution: Using the Reject Issues report, we’re able to easily view the quantity of Reject issues present within a Project, the breakdown of this total by study and data package, and the sum of Reject issues that are Unaddressed (present with a Status of Open, To Close, or Closed). We can delve deeper and view a table containing each Reject issue found in the Project and use this to quickly triage these issues so that they’re routed to the appropriate team member for resolution.

Case study 5: Standards Adoption
挑战:Our standards team has spent countless hours developing and maintaining standards for our organization, and we would like to know how many studies have employed each version of our standards.
P21E Solution: On the Standards Adoption report, we’re able to see the number of data packages configured with each version of the selected standard across Projects and Studies. Comparing this report against a Master Study list, we can also easily determine if any data packages have been configured with an incongruent version of a standard and request a team member take corrective action.

Case study 6: Leaderboards
挑战:We’ve been asked to provide a list of names of internal employees, as well as those within our FSP CRO’s, who should be presented with the opportunity to bear the special title of Pinnacle 21 Enterprise Guru and provide input on training materials, mentoring, and user feedback for our organization.
P21E Solution: By examining the Leaderboards report, it’s easy to see who the most active users in our environment are based on the number of validations run, issues managed and define/spec changes made. These categories will also allow us to indicate the specialty of each Guru and the visibility of each user’s email address allows us to determine each leader’s affiliation.
Pinnacle 21 Enterprise analytics of the future
As Pinnacle 21 Enterprise evolves, we will continue to incorporate our industry’s needs and technology in the expansion of our Analytics offerings.
Imagine the ability to automatically plug CTMS data directly into P21E to view study-specific milestones within relevant reports. Or how rewarding and reassuring it would feel to see your data package’s Data Fitness Score compared with other, similar de-identified Data Fitness Scores from across the industry, matched at similar study milestones, including at the time of submission to different regulatory agencies.
This is all within our reach, as the data exist, they simply need to be transformed into metrics and harnessed through the power of analytics, ingenuity, and a little imagination.
Learn more about Pinnacle 21 Enterprise
De-risk and expedite submissions by ensuring clinical data compliance. Learn more today!


Certara Pinnacle 21 产品高级总监
具有 20 年临床研究和医疗保健经验的创新领导者,专注于临床生物样本和数字化健康评估数据的获取、管理和转换。为制药行业提供技术化解决方案的协作创造者。多才多艺的分析总监,具有良好的人际交往和沟通能力,并具有在战略和战术层面上管理多职能团队的经验。主要优势包括推动转型变革、战略规划和执行、带头进行业务流程改进计划,以及组建高绩效的组织。在研发部门中制定和引入了无数的策略,以实现效率并解决业务流程和应用软件之间的差距。在业务运营监督和指导方面经验丰富,包括资源和财务预测及优先排序。